180 related articles for article (PubMed ID: 21250972)
21. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract][Full Text] [Related]
23. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
[TBL] [Abstract][Full Text] [Related]
24. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
Cerhan JR; Novak AJ; Fredericksen ZS; Wang AH; Liebow M; Call TG; Dogan A; Witzig TE; Ansell SM; Habermann TM; Kay NE; Slager SL
Br J Haematol; 2009 Jun; 145(5):614-23. PubMed ID: 19344414
[TBL] [Abstract][Full Text] [Related]
25. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
[TBL] [Abstract][Full Text] [Related]
26. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
Shen M; Zheng T; Lan Q; Zhang Y; Zahm SH; Wang SS; Holford TR; Leaderer B; Yeager M; Welch R; Kang D; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S; Rothman N
Hum Genet; 2006 Jul; 119(6):659-68. PubMed ID: 16738949
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
[TBL] [Abstract][Full Text] [Related]
29. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
[TBL] [Abstract][Full Text] [Related]
30. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
[TBL] [Abstract][Full Text] [Related]
31. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility for ischemic stroke in four constitution medicine is associated with polymorphisms of FCGR2A and IL1RN genes.
Lee BC; Lee H; Park HK; Yang JS; Chung JH
Neurol Res; 2010 Feb; 32 Suppl 1():43-7. PubMed ID: 20034444
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.
Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R
Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223
[TBL] [Abstract][Full Text] [Related]
34. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.
Kelly JL; Drake MT; Fredericksen ZS; Asmann YW; Liebow M; Shanafelt TD; Feldman AL; Ansell SM; Macon WR; Herr MM; Wang AH; Nowakowski GS; Call TG; Habermann TM; Slager SL; Witzig TE; Cerhan JR
Cancer Causes Control; 2012 Jul; 23(7):1017-29. PubMed ID: 22544453
[TBL] [Abstract][Full Text] [Related]
35. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
Colt JS; Rothman N; Severson RK; Hartge P; Cerhan JR; Chatterjee N; Cozen W; Morton LM; De Roos AJ; Davis S; Chanock S; Wang SS
Blood; 2009 Feb; 113(9):1899-905. PubMed ID: 19066394
[TBL] [Abstract][Full Text] [Related]
36. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
[TBL] [Abstract][Full Text] [Related]
38. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
[TBL] [Abstract][Full Text] [Related]
39. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjosé S; Vajdic CM; Zhang Y; Chiu BC; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM
Cancer Causes Control; 2013 Jan; 24(1):125-34. PubMed ID: 23160945
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population.
Suthandiram S; Gan GG; Zain SM; Haerian BS; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
J Hum Genet; 2014 May; 59(5):280-7. PubMed ID: 24646728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
